RDH12 rs3138142: Understanding This Retinal Variant

What each genotype means

What is rs3138142?

The rs3138142 variant is a single nucleotide polymorphism (SNP) situated within the RDH12 gene on chromosome 14. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is categorized as a non-synonymous change, meaning it has the potential to alter the amino acid sequence of the protein produced by the gene. The RDH12 gene is located at 14q24.1 and consists of nine exons that encode the retinol dehydrogenase 12 enzyme. Because this variant is located within a gene critical for eye function, researchers monitor it to determine if it influences the efficiency of the visual cycle or contributes to the development of retinal conditions. Currently, the evidence linking this specific SNP to clinical disease is limited, and it is often studied alongside other, more clearly pathogenic variants in the same gene.

The Role of the RDH12 Gene

The RDH12 gene encodes an enzyme called retinol dehydrogenase 12, which is primarily expressed in the photoreceptor cells of the retina. These cells are responsible for converting light into electrical signals that the brain interprets as vision. The RDH12 enzyme plays a vital role in the visual cycle, a complex biochemical process that recycles the light-sensitive molecules (chromophores) required for continuous sight. When this enzyme functions correctly, it helps maintain the health of the retina by preventing the accumulation of toxic byproducts that can damage photoreceptor cells. Mutations that significantly disrupt the function of RDH12 are well-documented causes of severe, early-onset retinal dystrophies, such as Leber congenital amaurosis and various forms of retinitis pigmentosa. Because of this, any variant within the gene, including rs3138142, is scrutinized for its potential to impact the stability or catalytic activity of the enzyme.

Research and Clinical Evidence

Scientific research into RDH12 has primarily focused on identifying biallelic (two-copy) mutations that cause severe, recessive retinal degeneration. While many variants in RDH12 are confirmed to be pathogenic, the evidence for rs3138142 is currently limited. Most studies on RDH12-associated retinopathy highlight that the phenotypic spectrum is broad, ranging from severe childhood blindness to milder, late-onset macular dystrophies. Because rs3138142 is found in the general population, it is often classified as a variant of uncertain significance in clinical databases unless it is found in combination with other known pathogenic mutations. It is important to note that the presence of a single variant in this gene does not necessarily indicate the presence of a disease. Researchers continue to use large-scale genomic sequencing to determine if this variant acts as a modifier of disease risk or if it is a benign polymorphism that does not significantly affect visual health.

Population Frequency

The rs3138142 variant is observed across various global populations, with a minor allele frequency of approximately 0.04 in individuals of European ancestry. This frequency indicates that the variant is relatively common and is not restricted to a single ethnic group. In genetic studies, a frequency of 4% suggests that a significant portion of the population carries at least one copy of this allele. Because it is present at this frequency, it is generally considered a common variant rather than a rare, highly penetrant mutation. Researchers compare these frequency data against clinical cohorts to see if the variant appears more often in individuals with retinal conditions than in the healthy population. If the frequency remains similar between both groups, it provides further evidence that the variant is likely benign and not a primary driver of retinal disease.

What You Can Do With This Information

Understanding your genetic profile can be an educational experience, but it is important to interpret results like rs3138142 with caution. Because the clinical significance of this variant is limited, it should not be used to predict the development of eye disease or to make medical decisions. Genetic testing results are complex and often require the context of a full clinical evaluation, including family history and specialized eye exams. If you have concerns about your vision or a family history of retinal conditions, the most appropriate step is to consult with an ophthalmologist or a genetic counselor. These professionals can provide a comprehensive assessment and explain how your specific genetic information relates to your overall health. Never use genetic data to self-diagnose or alter any medical treatments without first discussing the findings with a qualified healthcare provider.

Frequently asked questions

Sources & further reading